View Older Stories View More Recent Stories
-
Equity Metals Reports Assays from 2026 Validation Drilling on the No. 3 Vein and Active Q4 Exploration Initiatives, Silver Queen Project, BC
-
Aehr Test Systems to Announce First Quarter Fiscal 2027 Financial Results on November 2, 2026
-
Altamira Gold Drills 134m @ 0.5 g/t Gold and Trenches 114m @ 0.7 g/t Gold at the Maria Bonita Gold Deposit, Cajueiro Gold District, Brazil
-
Metals Creek Signs Drilling Contract for the Ogden Gold Project in Timmins, Ontario
-
StubHub Holdings (STUB) PT Lowered to $9 at Guggenheim
-
Skeleton Coast Uranium Identifies 42 Ranked Uranium Targets Across its Five Namibian Prospecting Licenses from Reinterpretation of Regional Airborne Geophysical Data
-
Baird Reiterates Outperform Rating on Costco Wholesale (COST)
-
Aritzia (ATZ:CN) (ATZAF) PT Lowered to Cdn$191 at BMO Capital
-
Critical One Announces Proposed Spin-Out of Kenora and Namibia Assets into 'Critical Two' and Engages Micon for Independent Review at Kenora Property
-
Lion Rock Appoints Retired US Air Force Colonel Leon Ray and Growth Executive James Winborn as Strategic Advisors
-
BMO Capital: 'Linde (LIN) Speaks to Electronics and Space as Double-Digit Growth Drivers'
-
Pfizer (PFE) PT Raised to $28 at Cantor Fitzgerald on Growing Sector Tailwinds
-
Craig-Hallum Starts Satellos Bioscience Inc (MSCL:CN) at Buy
-
Piper Sandler on Meta Platforms Inc. (META): 'META+ Still a Top Pick'
-
Merck (MRK) PT Raised to $145 at Cantor Fitzgerald - Outstanding ESMO Expected
-
Texas Capital Securities Reiterates Buy Rating on Applied Digital (APLD)
-
Constellation Brands (STZ) PT Lowered to $125 at Piper Sandler
-
GRG Resources Corp. Engages Marketing Consultants
-
Zenith Epigenetics Receives FDA Clearance for Registration Enabling Study of ZEN-3694 in NUT Carcinoma
-
Eli Lilly (LLY) PT Raised to $1,440 at Cantor Fitzgerald - Consensus Numbers Above Top-Line Guide
-
Devon Energy to sell Eagle Ford assets to Crescent Energy for $4.2B
-
Bristol-Myers Squibb Co. (BMY) PT Lowered to $53 at Cantor Fitzgerald on Anticipated Milvexian Pressure
-
Amgen (AMGN) PT Raised to $440 at Cantor Fitzgerald - 'Now a Clear Consensus Long'
-
Kaiser Aluminum Corporation (KALU) PT Lowered to $181 at KeyBanc
-
Carpenter Technology (CRS) PT Lowered to $465 at KeyBanc
-
ATI Inc. (ATI) PT Lowered to $228 at KeyBanc
-
ArriVent BioPharma (AVBP) PT Lowered to $27 at H.C. Wainwright
-
Abbvie (ABBV) PT Raised to $290 at Cantor Fitzgerald
-
Crescent Energy to buy Devon Energy Eagle Ford assets for $3.85B
-
Vir Biotechnology (VIR) PT Raised to $22 at H.C. Wainwright
-
Microchip launches two touch controllers with parallel sensing
-
Aurora Cannabis expands Germany facility, doubling expected flower output
-
Dyne Therapeutics (DYN) Reiterated at Overweight by Cantor Fitzgerald
-
H.C. Wainwright Reiterates Buy Rating on Connect Biopharma Holdings Ltd (CNTB)
-
KeyBanc on ServiceTitan (TTAN): 'Voice Agents Hugely Underappreciated'
-
H.C. Wainwright Reiterates Buy Rating on TOYO Co. (TOYO)
-
KeyBanc Reiterates Overweight Rating on Spotify (SPOT)
-
H.C. Wainwright Reiterates Buy Rating on Verastem (VSTM)
-
Eupraxia Pharmaceuticals (EPRX) Reiterated at Overweight by Cantor Fitzgerald - 'Stock Remains Undervalued'
-
Red Lake Gold closes first tranche of private placement at $0.075
-
H.C. Wainwright Reiterates Buy Rating on Helus Pharma (HELP)
-
Red Lake Gold Inc. Closes First Tranche of Private Placement
-
H.C. Wainwright Reiterates Buy Rating on Seaport Therapeutics (SPTX)
-
Devon in Talks to Sell $4.2 Billon Shale Oil Assets to Crescent - Bloomberg
-
USFM and Twin Vee revise merger terms, adjust ownership split
-
X4 Pharmaceuticals secures $150M debt facility with K2 HealthVentures
-
Gilat DataPath wins $8M in U.S. defense SATCOM orders
-
BioLineRx and Hemispherian to present GLIX1 data at SNO meeting
-
BioStem Technologies CEO and COO buy $1M in stock via options
-
First Majestic reports lower Q3 2026 silver and gold output
